Phytopharm PLC
15 January 2007
Phytopharm plc
Annual Information Update
Phytopharm plc (the Company) announces that, in accordance with the requirements
of Prospectus Rule 5.2 issued by the Financial Services Authority, and following
publication of the Annual Report on 28 December 2006, the following information
has been published or made available to the public during the 12 months ended 12
January 2007, in compliance with laws and rules dealing with the regulation of
securities, issuers of securities and securities markets.
For the purpose of this update, only references to the information are provided.
Full copies of each item can be found at the locations specified below. In
accordance with the provisions of Article 27.3 of the Prospectus Directive
Regulations, we confirm that to the best of our knowledge, information relating
to 'Holdings in Company' and 'Director/PDMR Shareholdings' is up to date at the
date of this announcement, but it is acknowledged that such disclosures may, at
any time, become out of date, due to changing circumstances.
1. Announcements made via Regulatory Information Services
All documents listed below were published via a regulatory information service
on the dates indicated:
Date of publication Title
10 January 2007 Director/PDMR shareholding
10 January 2007 Director/PDMR shareholding
9 January 2007 Board changes
19 December 2006 Notification of total voting rights
10 November 2006 Director/PDMR shareholding
8 November 2006 Preliminary results for the year ended 31 August 2006
1 November 2006 Block listing interim review
27 October 2006 Notification of results
18 September 2006 Block listing interim review
5 September 2006 Board changes
21 July 2006 Board appointment
5 June 2006 Board appointment
19 May 2006 Holding(s) in company
11 May 2006 Director/PDMR shareholding
11 May 2006 Director/PDMR shareholding
8 May 2006 Interim results
3 May 2006 Block listing interim review
27 April 2006 Holding(s) in company
27 April 2006 Holding(s) in company
26 April 2006 Advisor appointment
24 April 2006 Product launch
10 April 2006 Research update
30 March 2006 Notice of results
17 March 2006 Block listing interim review
30 January 2006 Second price monitoring extension
30 January 2006 Price monitoring extension
24 January 2006 Results of AGM
2. Documents despatched to shareholders
The following documents have been despatched by the Company to holders of its
securities during the year:
27 December 2006 - Annual Report 2006
1 June 2006 - Interim Report 2006
3. Documents field at Companies House
The Company has submitted the following Filings to Companies House:
11 January 2007 Form 288(a) Appointment of Director Mr Piers Morgan
11 January 2007 Form 288(b) Terminating appointment of Director - Dr
Richard Dixey
5 December 2006 Form 363 Annual Return
6 September 2006 Form 288(b) Terminating appointment of Director - Dr
Trevor Flanagan
6 September 2006 Form 288(b) Terminating appointment of Director - Mr
Gordon Stevens
24 July 2006 Form 288(a) Appointment of Director - Dr Peter Blower
8 June 2006 Form 288(a) Appointment of Director - Mr Alexander
Morrison
24 January 2006 Registration of special resolutions passed at AGM
Copies of these documents can be obtained from Companies House, Crown Way,
Cardiff CF14 3UZ (Telephone 0870 3333 636, email at
enquiries@companies-house.gov.uk) or, if you are a registered user,
through Companies House Direct at www.companies-house.gov.uk
The Company's annual report and accounts 2006 (published on 28 December 2006)
and Interim Report 2005 (published on 1 June 2006) can be found on the Company's
website as can the Interim Results announcement for the six months ended 28
February 2006 (published on 8 May 2006) and the Preliminary Results Announcement
(published on 8 November 2006), The Company's website is www.phytopharm.com.
Copies of all documents referred to above are also available for inspection at
the Company's registered office (Corpus Christi House, 9 West Street,
Godmanchester, Cambs PE29 2HY, United Kingdom) during normal business hours or
by request from the Company Secretary.
For further information, please contact:
Zoe McGowan, Company Secretary
Phytopharm plc Tel No: +44 (0)1480 437697
Further information, about Phytopharm can be found on the Company's website
www.phytopharm.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.